Hyperuricemia is associated with all risk factors of Metabolic syndrome and is viewed as a biomarker and therapeutic target for cardiometabolic treatments. This comprehensive review examines the multifaceted landscape of hyperuricemia delving into its epidemiology, intricate pathophysiology, diverse associations with health conditions and contemporary approaches to its management.
No takes yet. Share an insight, caveat, or question.
Soni et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: